William Blair, Sofi and Affirm

William Blair initiates coverage of digital finance stocks with an Outperform on SoFi, Affirm
SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the digital finance subsegment of fintech with an Outperform rating on the two stocks.
Fintech Leaders: SoFi and Affirm Shine as William Blair Kicks Off Coverage with Outperform Ratings
With Outperform ratings on both stocks, SoFi Technologies ( NASDAQ:SOFI) and Affirm Holdings ( NASDAQ:AFRM) shares moved higher on Wednesday after William Blair started coverage of the digital finance industry.
Sterling Infrastructure initiated with an Outperform at William Blair
William Blair last night initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating. Sterling’s “industry-leading” data
Affirm, SoFi Initiated At Outperform In Consumer Digital Financing
William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.
Cboe Global Markets initiated with a Market Perform at William Blair
William Blair initiated coverage of Cboe Global Markets (CBOE) with a Market Perform rating and no price target The firm does not expect multiple expansion for the shares as zero days to expiration options mature and the company’s derivatives revenue growth normalizes.
William Blair starts SoFi, Affirm with Outperform ratings
William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm
William Blair Boosts Earnings Estimates for LPL Financial
William Blair raised their Q4 2024 EPS estimates for LPL Financial in a report released on Monday, January 13th. William ...
Hosted on MSN3d
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
FierceBiotech2d
Neumora's dig into phase 3 depression data disappoints analysts
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
FY2025 EPS Estimates for MarketAxess Cut by William Blair
Equities research analysts at William Blair lowered their FY2025 earnings estimates for shares of MarketAxess in a research ...
bovnews10h
Enovix Corp (ENVX) Posted -1180.22% Profit Margin Last Year—Can It Hold Up?
Enovix Corp (ENVX) stock saw a modest uptick, ending the day at $10.95 which represents a slight increase of $0.17 or 1.58% from the prior close of $10.78. The stock opened at $10.75 and touched a low ...
QSR magazine2d
Portillo’s, Like Usual, Charts a Fresh Path with Guest Loyalty
Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...
Business Insider3d
William Blair upgrades CVRx on stabilization of business
William Blair analyst Margaret Kaczor upgraded CVRx (CVRX) to Outperform from Market Perform without a price target With now several solid quarters behind it following ithe Q1 of 2024 miss and ...
bovnews12h
Allakos Inc (ALLK) Stock: More Robust Than the Numbers Suggest?
Jefferies has recently reduced Allakos Inc (ALLK) stock to Hold rating, as announced on January 17, 2024, according to Finviz. Earlier, on January 16, 2024, Cantor Fitzgerald had reduced the stock ...